ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Antineoplastic Agents, Hormonal

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Therapeutic Uses ∟ Antineoplastic Agents ∟ Antineoplastic Agents, Hormonal 8 coordinate concepts ∟ Angiogenesis Inhibitors \| ∟ Antibiotics, Antineoplastic \| ∟ Anticarcinogenic Agents \| ∟ Antimetabolites, Antineoplastic \| ∟ Antimitotic Agents \| ∟ Antineoplastic Agents, Alkylating \| ∟ Antineoplastic Agents, Phytogenic \| ∟ Myeloablative Agonists X
Broader terms:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Therapeutic Uses ∟ Antineoplastic Agents ∟ Antineoplastic Agents, Hormonal Antineoplastic Agents > Therapeutic Uses > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) X
Annotation:	consider also NEOPLASMS, HORMONE-DEPENDENT /drug ther X
History note:	Antineoplastic Agents (1966-1995)X
historyNote*:	96 X
publicMeSHNote*:	96 X
Scope note:	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) X
activeMeSHYear*:	2006 \| 2007X
dateCreated*:	1995-05-26X
dateEstablished*:	1996-01-01X
dateRevised*:	2005-06-30X
recordAuthorizer*:	sjnX
recordMaintainer*:	ssbX
recordOriginator*:	JRTX
Type:	Concept X
Coordinate terms:	Angiogenesis Inhibitors \| Antibiotics, Antineoplastic \| Anticarcinogenic Agents \| Antimetabolites, Antineoplastic \| Antimitotic Agents \| Antineoplastic Agents, Alkylating \| Antineoplastic Agents, Phytogenic \| Myeloablative Agonists X
URI:	X
Labels and equivalent concepts:	Hormonaaliset solunsalpaajat (fi) Hormonaalinen sytostaatti (fi, replaced) Hormonaalinen syöpälääke (fi, replaced) Hormonaaliset syöpälääkkeet (fi, replaced) Hormonaaliset sytostaatit (fi, replaced) Hormonaalinen solunsalpaaja (fi, replaced) Cellgifter, hormonella (sv) Cytostatika, hormonella (sv, replaced) Cellhämmare, hormonella (sv, replaced) Hormonal Antineoplastics (en, replaced) Antineoplastic Hormonal Drugs (en, replaced) Antineoplastic Hormonal Agents (en, replaced) Antineoplastics, Hormonal (en, replaced) Hormonal Agents, Antineoplastic (en, replaced) Hormonal Antineoplastic Drugs (en, replaced) Hormonal Antineoplastic Agents (en, replaced) Antineoplastic Drugs, Hormonal (en, replaced) X
Share:	X